Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend cash money

.Turnstone Biologics is actually lowering its own headcount through 60% and shaking up its own C-sui...

Gilead surrenders on $15M MASH bet after mulling preclinical data

.In a year that has actually seen a confirmation and a raft of readouts for metabolic dysfunction-as...

Texas biotech axes cancer pact, pins wishes on excessive weight

.Alaunos Rehabs is actually axing an agreement along with Precigen, surrendering licensing civil lib...

Capricor reveals even more data for DMD treatment after triggering BLA

.Capricor Therapies is taking a success tour for their period 2 Duchenne muscular dystrophy (DMD) tr...

FDA spots Kezar lupus test in hold following 4 individual fatalities

.The FDA has put Kezar Life Sciences' lupus trial on grip after the biotech hailed 4 deaths during t...

Phase 3 Historian Rock trial hits SMA goal, sending out stock up 200%

.A phase 3 trial of Historian Rock's spinal muscular atrophy (SMA) candidate has actually reached it...

CAMP 4 is actually most recent to eye IPO, while Upstream describe $182M planning

.RNA biotech CAMP4 Therapeutics has defined plans for a $67 thousand IPO, along with inflammation-fo...

Galecto purchases leukemia medicine, drops bone cancer property in pivot

.A year after the failure of an idiopathic pulmonary fibrosis applicant sent Galecto on a search for...

Judo throws down $100M to knock out kidney health condition

.Taking the mat is Judo Biography, a promising biotech armed along with $100 million to create oligo...

AstraZeneca pays out CSPC $100M for preclinical heart disease drug

.AstraZeneca has actually paid off CSPC Drug Group $100 thousand for a preclinical heart disease med...